These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27756569)

  • 41. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.
    Yasuda A; Sawai H; Takahashi H; Ochi N; Matsuo Y; Funahashi H; Sato M; Okada Y; Takeyama H; Manabe T
    Mol Cancer; 2006 Oct; 5():46. PubMed ID: 17044945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development.
    Shen Z; Li Y; Fang Y; Lin M; Feng X; Li Z; Zhan Y; Liu Y; Mou T; Lan X; Wang Y; Li G; Wang J; Deng H
    Mol Oncol; 2020 Feb; 14(2):387-406. PubMed ID: 31876369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
    Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
    Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer.
    Zhang Y; Zhang J; Xu K; Xiao Z; Sun J; Xu J; Wang J; Tang Q
    Hepatogastroenterology; 2013 Oct; 60(127):1766-72. PubMed ID: 24624456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray.
    Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW
    Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells.
    Kim D; Hong A; Park HI; Shin WH; Yoo L; Jeon SJ; Chung KC
    J Cell Physiol; 2017 Dec; 232(12):3664-3676. PubMed ID: 28160502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Wang Y; Guo H; Zhang D; Yu X; Leng X; Li S; Zhu W
    Biochem Biophys Res Commun; 2016 Oct; 479(3):510-516. PubMed ID: 27663663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C-terminal tensin-like gene functions as an oncogene and promotes cell motility in pancreatic cancer.
    Al-Ghamdi S; Cachat J; Albasri A; Ahmed M; Jackson D; Zaitoun A; Guppy N; Otto WR; Alison MR; Kindle KB; Ilyas M
    Pancreas; 2013 Jan; 42(1):135-40. PubMed ID: 22750970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer.
    Zheng L; Zhou Z; He Z
    Int J Clin Exp Pathol; 2015; 8(11):14005-12. PubMed ID: 26823712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIC1 attenuates invasion and metastasis by inhibiting the IL-6/STAT3 signalling pathway in human pancreatic cancer.
    Hu B; Zhang K; Li S; Li H; Yan Z; Huang L; Wu J; Han X; Jiang W; Mulatibieke T; Zheng L; Wan R; Wang X; Hu G
    Cancer Lett; 2016 Jul; 376(2):387-98. PubMed ID: 27085461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
    Fujisawa T; Joshi B; Nakajima A; Puri RK
    Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.
    Roessler M; Rollinger W; Mantovani-Endl L; Hagmann ML; Palme S; Berndt P; Engel AM; Pfeffer M; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
    Mol Cell Proteomics; 2006 Nov; 5(11):2092-101. PubMed ID: 16893879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer.
    Qin X; Wang X; Liu F; Morris LE; Wang X; Jiang B; Zhang Y
    Cancer Lett; 2016 Jun; 376(1):83-94. PubMed ID: 26975632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL24 and its Receptors Regulate Growth and Migration of Pancreatic Cancer Cells and Are Potential Biomarkers for IL24 Molecular Therapy.
    Jia Y; Ji KE; Ji J; Hao C; Ye L; Sanders AJ; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1153-63. PubMed ID: 26977011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
    Shukla SK; Dasgupta A; Mehla K; Gunda V; Vernucci E; Souchek J; Goode G; King R; Mishra A; Rai I; Nagarajan S; Chaika NV; Yu F; Singh PK
    Oncotarget; 2015 Dec; 6(38):41146-61. PubMed ID: 26510913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells.
    Liu C; Zhang H; Zang X; Wang C; Kong Y; Zhang H
    Diagn Pathol; 2015 Apr; 10():30. PubMed ID: 25907906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Roles of Fyn in pancreatic cancer metastasis.
    Chen ZY; Cai L; Bie P; Wang SG; Jiang Y; Dong JH; Li XW
    J Gastroenterol Hepatol; 2010 Feb; 25(2):293-301. PubMed ID: 19968749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.